Uniwersytecki Szpital Dzieciecy W Lublinie
- Address
- lock Available on a paid plan
Oncology and Hematology Research
At Uniwersytecki Szpital Dzieciecy W Lublinie, clinical trials in neoplasms and hemic and lymphatic diseases focus on childhood cancers such as acute lymphoblastic leukemia, relapsed ALL, lymphoblastic lymphoma, and myeloid leukemia in children with Down syndrome. The studies are designed to improve treatment effectiveness, reduce relapse risk, and support safer cancer care for young patients.
- Testing new treatment combinations for acute lymphoblastic leukemia and relapsed ALL
- Evaluating strategies to improve remission, survival, and minimal residual disease response
- Supporting safer and more effective care in pediatric oncology
This area also includes work on hematopoietic stem cell transplantation in pediatric leukemia, reflecting a strong focus on advanced therapies for children with high-risk disease.
Transplantation and Immune System Studies
The site conducts research on HSCT, graft-versus-host disease, and immune-related complications in children with leukemia. These trials aim to refine transplant care, lower treatment-related toxicity, and preserve the beneficial anti-leukemia effect of transplantation.
- Improving stem cell transplantation approaches in pediatric ALL
- Studying ways to reduce transplant-related toxicity while maintaining disease control
- Evaluating treatments for acute graft-versus-host disease and post-transplant relapse prevention
The research includes cooperative efforts on transplant conditioning, donor-related strategies, and maintenance therapy after HSCT.
Kidney and Metabolic Diseases
Trials in nutritional and metabolic diseases and pathological conditions address pediatric kidney disorders and early diabetes-related disease. Key conditions include nephrotic syndrome, IgA nephropathy, chronic kidney disease, and presymptomatic type 1 diabetes. The goal is to improve disease control and evaluate new treatment options in children.
- Assessing therapies for proteinuria and kidney inflammation
- Studying treatments for chronic kidney disease in children at risk of progression
- Exploring early immune-based intervention in stage 1 type 1 diabetes
These studies reflect a broad pediatric nephrology and metabolic research profile at the Lublin children’s hospital.
Rheumatology and Autoimmune Care
Research in immune system diseases and skin and connective tissue diseases includes pediatric juvenile idiopathic arthritis, juvenile psoriatic arthritis, and lichen sclerosus. The trials are focused on testing new therapies, understanding treatment response, and improving symptom control in chronic inflammatory conditions.
- Evaluating biologic and targeted treatments for juvenile arthritis
- Comparing therapies for pediatric vulval lichen sclerosus
- Studying safety, effectiveness, and patient response in autoimmune disease care
This work helps expand treatment options for children with long-term inflammatory disorders treated at the hospital.
Bleeding and Blood Disorder Research
The site also investigates hemophilia, chronic immune thrombocytopenic purpura, and related bleeding disorders. These studies aim to reduce bleeding episodes, improve prophylactic care, and better manage platelet and clotting problems in children.
- Testing new approaches to prevent bleeding in hemophilia A and B
- Evaluating treatment options for chronic ITP
- Improving long-term management of pediatric bleeding disorders
The research contributes to safer and more effective care for children with inherited or immune-mediated blood disorders.
Supportive Care in Pediatric Cancer
A further part of the trial portfolio addresses chemotherapy-induced nausea and vomiting in children receiving cancer treatment. These studies focus on improving comfort, tolerability, and overall quality of care during intensive therapy.
- Comparing approaches to prevent nausea and vomiting during cancer therapy
- Assessing supportive treatments that may improve the treatment experience for young patients
- Strengthening pediatric oncology supportive care
This research complements the hospital’s broader oncology program by addressing side effects that can affect treatment adherence and wellbeing.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 15 of 80 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 80 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
- 1GPOH gGmbH2active
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1GPOH gGmbH2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Uniwersytecki Szpital Dzieciecy W Lublinie
lock Showing 1 of 23 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Double-Blind, Randomized Study Comparing the Safety and Efficacy of Vedolizumab Versus Infliximab in Pediatric Ulcerative Colitis Patients | Instytut Pomnik Centrum Zdrowia Dziecka | Phase II | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 80 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytarabine | 7 | Unknown | 2017-10-02 | 2024-11-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.